Skip to main content

New top story from Time: FDA Panel Greenlights First Single-Shot COVID-19 Vaccine, from Johnson & Johnson

https://ift.tt/3pZf3dk

The U.S. Food and Drug Administration’s (FDA) vaccine advisory committee earlier today (Feb. 26) voted unanimously to recommend Johnson & Johnson’s COVID-19 vaccine for emergency use authorization. While the FDA isn’t obligated to follow the committee’s advice, it generally does.

At the end of a full day of review and discussion of the company’s shot, all 22 voting members of the committee agreed that the vaccine was safe and effective enough to be used by the public. It’s the third vaccine that the group of independent experts has recommended, following Pfizer-BioNTech and Moderna. Unlike the two previous vaccines, J&J’s is a single shot, and can be shipped and stored under refrigerated, not frozen conditions, as the other two require.

The single dosing played a part in the committee’s decision. Logistically, vaccinating people one time is much easier than asking them to return for a second dose. “This was a relatively easy call,” Dr. Eric Rubin, editor in chief of the New England Journal of Medicine and professor at Harvard T.H. Chan School of Public Health, who voted to recommend the shot said during the discussion. “[The vaccine] clearly gets way over the bar of safety and efficacy, and it’s a single-dose vaccine.”

The committee members reviewed data presented by Janssen Pharmaceuticals, the J&J arm that developed the vaccine, as well as FDA scientists’ review of that data. Janssen’s vaccine uses a different technology than Pfizer-BioNTech and Moderna, which both relied on a new platform involving mRNA. Janssen’s vaccine, on the other hand, is made with a weakened cold virus that can’t cause disease, manipulated so that it carries the genes for making one of the key proteins of SARS-CoV-2, the virus that causes COVID-19. Once that viral protein is introduced to the body, human immune cells learn to recognize it as foreign and launch attacks against it.

In Janssen’s primary vaccine study, involving nearly 44,000 people, a single dose was found to be 66% effective in protecting people from moderate to severe COVID-19 disease. It was slightly less effective in protecting against new variants of the virus—against one that was first identified in South Africa, it was around 57%. Still, that protection met the threshold of 50% efficacy set by the FDA for granting emergency use authorization.

Committee members raised questions about how much of the immune response to the COVID-19 virus might be blunted by a response mounted against the weakened cold virus used as the delivery vessel, a well known effect using this vaccine platform. Such vaccines are also potentially less effective when boosted with additional shots since the body becomes tolerant to the weakened virus vector. However, Dr. Johan Van Hoof, managing director of Janssen Vaccines and Prevention, noted that tests on the company’s HIV vaccine candidate using similar technology have shown that people boosted with additional shots years after the first continued to generate strong immune responses that didn’t seem to be significantly affected by the weakened virus vector.

Many committee members raised questions about the company’s data showing that the vaccine produced a slightly lower response in terms of antibody levels against the virus among people over age 60, especially those with underlying health conditions—a group particularly vulnerable to COVID-19. However, Janssen studies found that these people still did not develop severe COVID-19 disease or need hospitalization compared to people getting placebo. In fact, the vaccine was 85% effective in protecting people from severe disease and overall there were only 21 deaths among the 44,000 people studied; five occurring among those who were vaccinated and the remainder among the placebo group. None of the deaths were considered related to the vaccine.

The FDA scientists did note in their review that some participants in the study did experience serious side effects, including tinnitus (ringing in the ears), clotting and hives—which could be related to the vaccine and are worth further follow up. However, these were rare, and overall the vaccine was safe with most who reported side effects having only mild to moderate reactions including headache, chills and muscle aches.

The other question that continued to pop up during the day-long discussion focused on whether Janssen’s vaccine is really a one-shot vaccine or whether it, like the Pfizer-BioNTech and Moderna vaccines, actually requires a two-shot regimen. While the data the company submitted were from a trial in which participants were given only a single dose, the company is currently conducting another study of 30,000 people who will receive two doses of the shot—to see if an additional booster will raise immune responses even further.

If two doses prove to be more effective, it will raise a tricky question about what to do with people who might receive the single dose shot in coming weeks or months, should the one-dose regimen be authorized. Van Hoof argues that this is a question worth putting off for later, given the urgency of the current situation. “We feel the results of the study of our single dose showed high efficacy against severe disease, especially hospitalizations and death, and in a situation of mass vaccination programs, our regimen is extremely well positioned to be used during the outbreak,” he said.

Then of course there is the question of the recently identified genetic variants of SARS-CoV-2 that appear even more infectious than the original virus. Pfizer-BioNTech and Moderna did not have to deal with that when they submitted their requests back in December 2020, but the companies have since conducted additional tests that have shown that their vaccines remain effective in protecting against the major new mutations. Janssen’s submission to the FDA included some early data on the efficacy of its vaccine against the new variants, and Van Hoof told the committee that the company plans to continue genetic sequencing virus from people in the company’s trials if they test positive and will include that information in the final request for full approval which could come later this year. In the meanwhile, Janssen—like Pfizer-BioNtech and Moderna—is already working on a next-generation vaccine specifically targeting the new variants that could begin human testing by summer.

The FDA committee’s decision to recommend the Janssen shot now goes to the agency. If the FDA agrees to grant the emergency use authorization, the next step will be for the Centers for Disease Control and Prevention’s immunization committee to work out details of who should be vaccinated with the new shot, and the logistics for how to make that happen. That CDC committee will also likely make decisions about whether certain groups should be targeted to receive this specific vaccine, and what advice to provide vaccinators when people ask about whether they will need a second shot. That information won’t be available until Janssen completes its two-dose study in coming months.

Comments

Popular posts from this blog

New top story from Time: House Passes President Biden’s $1.9 Trillion COVID-19 Relief Bill

https://ift.tt/2ZVMCSX WASHINGTON — The House approved a $1.9 trillion pandemic relief bill in a win for President Joe Biden, even as top Democrats tried assuring agitated progressives that they’d revive their derailed drive to boost the minimum wage. The new president’s vision for flushing cash to individuals, businesses, states and cities battered by COVID-19 passed on a near party-line 219-212 vote early Saturday. That ships the massive measure to the Senate, where Democrats seem bent on resuscitating their minimum wage push and fights could erupt over state aid and other issues. Democrats said the still-faltering economy and the half-million American lives lost demanded quick, decisive action. GOP lawmakers, they said, were out of step with a public that polling shows largely views the bill favorably. “I am a happy camper tonight,” Rep. Maxine Waters, D-Calif., said Friday. “This is what America needs. Republicans, you ought to be a part of this. But if you’re not,

New top story from Time: Latest Tests Bring Israel a Step Closer to Commercial Drones

https://ift.tt/3lyZxGe TEL AVIV, Israel — Dozens of drones floated through the skies of Tel Aviv on Monday, ferrying cartons of ice cream and sushi across the city in an experiment that officials hope provided a glimpse of the not-too-distant future. Israel’s National Drone Initiative, a government program, carried out the drill to prepare for a world in which large quantities of commercial deliveries will be made by drones to take pressure off highly congested urban roads. The two-year program aims to apply the capabilities of Israeli drone companies to establish a nationwide network where customers can order goods and have them delivered to pick up spots. [time-brightcove not-tgx=”true”] The project, now in the third of eight stages, is still in its infancy and faces many questions about security and logistics. “We had 700 test flights at the start of this year and now we are close to 9,000 flights,” said Daniella Partem, from Israel Innovation Authority, a partner in th

https://ift.tt/eA8V8J सिद्धार्थ रॉय कपूर फिल्म्स कि अगली सीरीज़ विलियम डेलरिम्पल कि बेस्टसेलर, 'द एनार्की: पर आधारित होगी

सिद्धार्थ रॉय कपूर के प्रोडक्शन 'रॉय कपूर फिल्म्स' ने हालही में अवार्ड विनिंग इतिहासकार और लेखक विलियम डेलरिम्पल की बेस्ट सेलिंग हिस्टोरिकल बुक ‘द अनार्की: द रिलेंटलेस राइज़ ऑफ़ द ईस्ट इंडिया कंपनी' के आधिकारिक राइट्स हासिल कर इसे सीरीज़ के from टेलीविजन की खबरें | Television News in Hindi | TV Serials Update in Hindi – FilmiBeat Hindi http:/hindi.filmibeat.com/television/siddharth-roy-kapoor-next-web-series-will-be-based-on-anarchy-090499.html?utm_source=/rss/filmibeat-hindi-television-fb.xml&utm_medium=23.11.231.156&utm_campaign=client-rss

New top story from Time: Japan’s Prime Minister Abe Reportedly Stepping Down Over Health Concerns

https://ift.tt/32yNoGh (TOKYO) — Japan’s Prime Minister Shinzo Abe has expressed his intention to step down due to his declining health, according to reports Friday by NHK and other Japanese media. The Prime Minister’s Office said the report could not be immediately confirmed, but that Abe was believed to be meeting top ruling officials at the party headquarters. The Liberal Democratic Party spokesman did not answer the phone. Concerns about Abe’s chronic health issues, simmering since earlier this summer, intensified this month when he visited a Tokyo hospital two weeks in a row for unspecified health checkups. Abe, whose term ends in September 2021, is expected to stay on until a new party leader is elected and formally approved by the parliament. He had abruptly resigned from his first stint in office in 2007 due to his health, which was fueling concerns about his recent condition. Abe on Monday became Japan’s longest serving prime minister by consecutive days in of

New top story from Time: Justice Department Charges 8 in Chinese Harassment Plot in U.S.

https://ift.tt/37P9856 (WASHINGTON) — The Justice Department has charged eight people with working on behalf of the Chinese government in a pressure campaign aimed at coercing a New Jersey man who was wanted by Beijing into returning to China to face charges, officials said Wednesday. The prosecution, which Justice Department officials said was the first of its kind, accuses the defendants of participating in a Chinese government operation known as “Fox Hunt” that was ostensibly created to help Beijing locate fugitives abroad but that U.S. officials say in practice relied on intimidation and bullying to go after dissidents and political opponents. Five of the eight, including an American private investigator who was hired as part of the effort, were arrested Wednesday. The other three are believed to be in China. All eight were charged with conspiring to act as illegal agents for China in a case filed in federal court in Brooklyn. “Without coordination with our governmen

New top story from Time: The Reopening of Springsteen on Broadway Brought Broadway Out of Hibernation—and One Packed Theater Into a Brighter Future

https://ift.tt/3A6wS0a The city that never sleeps is still a little sleepy, unsure of how to move its joints and muscles as it awakens from its forced hibernation . Although Times Square is now almost as brightly lit as ever, it’s remarkably hard to find a bar that will serve a drink after 11 p.m. On a late-June Saturday night, Eighth Ave. around 42nd Street was vibrating with young people: guys imported from the outer boroughs and beyond in their baggy, rumpled shorts, young women in elastic spangled mini-dresses making their first outing after a year lying in a drawer, men in mardi gras beads and the tiniest of tank tops ready to make the most of the final days of Pride month . Yet it was hard to know exactly what all these people were doing there, other than taking their place in a kind of Brownian-movement minuet under the cheerfully garish lights. Because Times Square cannot be itself while Broadway—meaning not the actual street but the constellation of live shows around

More 20 MPH Streets Coming Soon Near You

More 20 MPH Streets Coming Soon Near You By Christine Osorio Last October when California Assembly Bill 43 (Friedman) was signed into law, we posted a blog about which gave cities new flexibility in setting speed limits—specifically reducing them. “Speed Management,” a reference that is still in development, focused on reducing speed limits in key business activity districts where at least 50% are dining or retail. Since the bill went into effect last month, we’ve already started lowering speed limits by 5 MPH (from 25 MPH to 20 MPH) in the first phase of approved corridors, four of which have been implemented:  San Bruno Avenue, from Silver to Paul avenues (Completed January 2022)  Polk Street, from Filbert to Sutter streets (Completed January 2022)  Haight Street, from Stanyan Street to Central Avenue and from Webster to Steiner streets (Completed February 2022)  24th Street, from Diamond to Chattanooga streets and from Valencia Street to San Bruno Avenue (Completed

New top story from Time: Department of Homeland Security Warns of Politically Motivated Violence

https://ift.tt/2NINiIA WASHINGTON — The Department of Homeland Security issued a national terrorism bulletin Wednesday warning of the lingering potential for violence from people motivated by antigovernment sentiment after President Joe Biden’s election, suggesting the Jan. 6 riot at the Capitol may embolden extremists and set the stage for additional attacks. The department did not cite any specific plots, but pointed to “a heightened threat environment across the United States” that it believes “will persist” for weeks after Biden’s Jan. 20 inauguration. It is not uncommon for the federal government to warn local law enforcement through bulletins about the prospect for violence tied to a particular event or date, such as July 4. But this particular bulletin, issued through the department’s National Terrorism Advisory System, is notable because it effectively places the Biden administration into the politically charged debate over how to describe or characterize acts

In-Person Pride Parade & Celebrations Return This Month!

In-Person Pride Parade & Celebrations Return This Month! By Pamela Johnson The SFMTA is happy to join San Francisco Pride celebrations when they return to in-person events this month as the city continues its recovery from the pandemic. This year’s theme is “Love will Keep Us Together.” The Trans March is happening on Friday, June 24 and the Pride Parade is on Sunday, June 26. SFMTA staff are, of course, an important part of the LGBTQIA+ community that keeps SF moving with Pride. Pride is an opportunity for us to demonstrate our continued support of the LGBTQIA+ community, promoting our core values of respect, inclusivity and integrity.  History/Background of SF Pride   San Francisco had its first Pride celebration in 1970. For more than three decades the LGBTQIA+ community and their allies have been moving San Francisco forward to become a better, safer, and more equitable world for the LGBTQIA+ community and the city a better place for people to live, work and enjoy.    His

New top story from Time: ‘Do Not Hold Grudges.’ Joe Biden’s Notes Reveal Talking Points About Kamala Harris

https://ift.tt/2X4natB (WILMINGTON, Del.) — Joe Biden was uncharacteristically tight-lipped on Tuesday about the final stretch of his search for a vice president. But the presumptive Democratic presidential nominee seemed prepared to talk about at least one leading contender: California Sen. Kamala Harris. As he took questions from reporters on Tuesday, Biden held notes that were captured by an Associated Press photographer. Harris’ name was scrawled across the top, followed by five talking points. “Do not hold grudges.” “Campaigned with me & Jill.” “Talented.” “Great help to campaign.” “Great respect for her.” Those are all observations Biden has made about Harris before. But they take on new significance following a recent Politico report that one of Biden’s closest friends and a co-chair of his vice presidential vetting committee, former Connecticut Sen. Chris Dodd, still harbors concerns about Harris’ tough debate stage performance and that she hasn’t expressed reg